PMS2 and cancer: Our study demonstrates that MLH1-/PMS2-/MSH6- digestive system cancer cases are a rare subgroup of dMMR cancers, that account for 1.4% of all cases in our cohort and do not only occur in CRCs but also in ampullary as well as gastric cancer.